Johnson & Johnson vs UnitedHealth Group
Johnson & Johnson (JNJ), health care, and UnitedHealth Group (UNH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Johnson & Johnson is worth $675.9B on the stock market and UnitedHealth Group $356.7B: Johnson & Johnson is valued at 90% more. Johnson & Johnson trades at 42.6 times earnings and UnitedHealth Group at 22.7. Over the past year Johnson & Johnson's share price has moved +41.3% and UnitedHealth Group's +31.4%.
Key facts
- Johnson & Johnson market value
- $675.9B
- UnitedHealth Group market value
- $356.7B
- Johnson & Johnson P/E
- 42.6
- UnitedHealth Group P/E
- 22.7
- Johnson & Johnson revenue
- $94.2BFY to 2025-12-28
- UnitedHealth Group revenue
- $447.6BFY to 2025-12-31
- Superinvestors holding both
- 12
Market values as of .
| Measure | Johnson & Johnson | UnitedHealth Group |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-28 | 2025-12-31 |
| Size | ||
| Market cap | $675.9Bhigher | $356.7Blower |
| Revenue | $94.2Blower | $447.6Bhigher |
| Earnings | $26.8Bhigher | $12.1Blower |
| Employees | 138,200lower | 390,000higher |
| Total assets | $199.2Blower | $309.6Bhigher |
| Valuation | ||
| P/E | 42.6higher | 22.7lower |
| P/S | 7.2higher | 0.8lower |
| P/B | 8.3higher | 3.6lower |
| Dividend yield | 1.87%lower | 2.20%higher |
| Profitability | ||
| Operating margin | — | 4.24% |
| Balance sheet | ||
| Net assets | $81.5Blower | $100.1Bhigher |
| Total liabilities | $117.7Blower | $207.9Bhigher |
| Total debt | $47.9Blower | $77.7Bhigher |
| Cash on hand | $19.7Blower | $24.4Bhigher |
| Price change | ||
| Today | -0.62%higher | -3.39%lower |
| 1 year | +41.3%higher | +31.4%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (12)
- Tweedy, Browne team4.1% / 0.1%
- Stephen Yacktman4.0% / 0.8%
- Jeremy Grantham (co-founder)4.0% / 2.2%
- Ken Fisher1.1% / 1.1%
- Mairs & Power team0.9% / 1.7%
- Andrew Spokes0.7% / 2.0%
- Charles Brandes (founder)0.3% / 1.0%
- Cliff Asness0.3% / 0.3%
- Ken Griffin0.2% / 0.3%
- Jensen team0.1% / <0.1%
- Rajiv Jain<0.1% / 0.8%
- Dodge & Cox team<0.1% / 1.6%
Johnson & Johnson only (11)
- Mark Boyar2.6%
- Tom Gayner1.3%
- Fred DiSanto1.1%
- Ray Dalio (founder)0.7%
- Mario Gabelli0.2%
- George Soros0.1%
- John Rogers0.1%
- Murray Stahl0.1%
- Christopher Bloomstran<0.1%
- Howard Gleicher<0.1%
- Thomas Russo<0.1%
UnitedHealth Group only (17)
- Samantha McLemore5.2%
- Sequoia Fund team4.2%
- Bill Smead2.5%
- Christopher Davis2.0%
- Lew Sanders2.0%
- Doug Silverman1.4%
- Pat English1.4%
- Jim Simons (1938–2024)1.1%
- Duan Yongping0.9%
- Steve Cohen0.5%
- Paul Tudor Jones0.5%
- Chase Coleman0.5%
- Temasek0.5%
- C.T. Fitzpatrick0.5%
- Israel Englander0.5%
- Robert Pitts0.4%
- Sarah Ketterer0.3%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Johnson & Johnson / UnitedHealth Group). Who owns JNJ · Who owns UNH
More on Johnson & Johnson
Further comparisons
Johnson & Johnson against its closest peers
UnitedHealth Group against its closest peers
Learn
Questions and answers
Which is bigger, Johnson & Johnson or UnitedHealth Group?
By market value, Johnson & Johnson is the larger: $675.9B against $356.7B for UnitedHealth Group. By revenue in its latest fiscal year, UnitedHealth Group is the larger: $447.6B against $94.2B for Johnson & Johnson.
Which has the higher P/E ratio?
Johnson & Johnson: 42.6, against 22.7 for UnitedHealth Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher dividend yield?
UnitedHealth Group: 2.20%, against 1.87% for Johnson & Johnson. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
UnitedHealth Group: $77.7B, against $47.9B for Johnson & Johnson. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Johnson & Johnson and UnitedHealth Group?
In their latest 13F filings, Tweedy, Browne team, Stephen Yacktman, Jeremy Grantham (co-founder), Ken Fisher, Mairs & Power team, Andrew Spokes, Charles Brandes (founder), Cliff Asness, Ken Griffin, Jensen team, Rajiv Jain and Dodge & Cox team hold both.
Cite this page
Funkfolio, “Johnson & Johnson vs UnitedHealth Group”, data as of 17 November 2026. https://funkfolio.com/compare/jnj-vs-unh
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.